A detailed history of Black Rock Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,565,086 shares of PTCT stock, worth $231 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,565,086
Previous 7,634,122 0.9%
Holding current value
$231 Million
Previous $210 Million 4.6%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$24.15 - $31.95 $1.67 Million - $2.21 Million
-69,036 Reduced 0.9%
7,565,086 $220 Million
Q4 2023

Feb 13, 2024

BUY
$18.07 - $29.37 $12.6 Million - $20.5 Million
699,673 Added 10.09%
7,634,122 $210 Million
Q3 2023

Nov 13, 2023

BUY
$22.41 - $41.99 $1.53 Million - $2.86 Million
68,106 Added 0.99%
6,934,449 $155 Million
Q2 2023

Aug 11, 2023

BUY
$40.4 - $59.1 $24.1 Million - $35.2 Million
596,353 Added 9.51%
6,866,343 $279 Million
Q1 2023

May 12, 2023

SELL
$38.16 - $48.86 $12 Million - $15.4 Million
-315,572 Reduced 4.79%
6,269,990 $304 Million
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $16 Million - $26.1 Million
477,145 Added 7.81%
6,585,562 $251 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $5.68 Million - $7.31 Million
135,795 Added 2.27%
6,108,417 $307 Million
Q2 2022

Aug 12, 2022

SELL
$25.6 - $45.23 $6.98 Million - $12.3 Million
-272,795 Reduced 4.37%
5,972,622 $239 Million
Q1 2022

May 12, 2022

SELL
$33.33 - $44.6 $4.82 Million - $6.45 Million
-144,524 Reduced 2.26%
6,245,417 $233 Million
Q4 2021

Feb 10, 2022

SELL
$35.36 - $41.86 $3.99 Million - $4.72 Million
-112,792 Reduced 1.73%
6,389,941 $255 Million
Q3 2021

Nov 09, 2021

SELL
$37.01 - $44.74 $615,624 - $744,205
-16,634 Reduced 0.26%
6,502,733 $242 Million
Q2 2021

Aug 11, 2021

BUY
$37.95 - $49.37 $247 Million - $322 Million
6,519,367 New
6,519,367 $276 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.19B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.